RASTETTER WILLIAM H 4

What Happened William H. Rastetter, a director of Dare Bioscience (DARE), was granted a derivative award on 2026-06-11 covering 10,000 shares. The filing shows an acquisition price of $0.00 (a stock option grant/award), so no cash was paid by the insider at grant. This is an award rather than a purchase or sale of already-issued shares.

Key Details

• Transaction date: 2026-06-11; Transaction type/code: A (Grant/Award of a derivative security).
• Amount: 10,000 underlying shares; reported price: $0.00.
• Shares owned after transaction: not specified in the Form 4 provided.
• Vesting/exercisability (footnote): vests in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting after the grant date, subject to continued service; becomes exercisable in full upon a change in control.
• Filing timeliness: Reported on 2026-06-11 (same date as the transaction), so the filing appears timely.

Context This was a director compensation award (an option-style derivative) that vests within roughly a year, not an immediate purchase or sale. Such grants are common as board compensation and do not by themselves indicate buying or selling sentiment; they grant the right to acquire stock in the future and may become exercisable upon a change in control.